Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) – Stock analysts at KeyCorp lifted their FY2023 EPS estimates for Integral Ad Science in a note issued to investors on Sunday, July 30th. KeyCorp analyst J. Patterson now forecasts that the company will earn $0.10 per share for the year, up from their prior estimate of $0.09. KeyCorp has a “Sector Weight” rating on the stock. The consensus estimate for Integral Ad Science’s current full-year earnings is $0.13 per share. KeyCorp also issued estimates for Integral Ad Science’s FY2024 earnings at $0.20 EPS.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last issued its earnings results on Thursday, May 4th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. Integral Ad Science had a net margin of 4.08% and a return on equity of 2.17%. The firm had revenue of $106.09 million during the quarter, compared to analyst estimates of $103.18 million.
IAS has been the subject of several other research reports. Benchmark assumed coverage on shares of Integral Ad Science in a research note on Tuesday, June 6th. They set a “hold” rating for the company. Raymond James lifted their price objective on shares of Integral Ad Science from $19.00 to $23.00 in a report on Wednesday, June 14th. Truist Financial initiated coverage on shares of Integral Ad Science in a research report on Thursday, July 20th. They set a “buy” rating and a $25.00 price objective for the company. Barclays boosted their target price on Integral Ad Science from $20.00 to $21.00 in a report on Wednesday, July 19th. Finally, Piper Sandler raised their price objective on shares of Integral Ad Science from $21.00 to $23.00 in a research note on Friday, July 14th. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Integral Ad Science currently has an average rating of “Moderate Buy” and a consensus price target of $19.00.
Integral Ad Science Trading Up 2.6 %
NASDAQ IAS opened at $20.85 on Tuesday. The stock has a market cap of $3.23 billion, a P/E ratio of 208.50 and a beta of 1.58. Integral Ad Science has a 12-month low of $6.63 and a 12-month high of $20.88. The company has a fifty day simple moving average of $18.68 and a two-hundred day simple moving average of $15.07. The company has a current ratio of 4.01, a quick ratio of 4.01 and a debt-to-equity ratio of 0.26.
Insiders Place Their Bets
In other news, insider Tom Sharma sold 4,157 shares of the business’s stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $16.00, for a total transaction of $66,512.00. Following the completion of the transaction, the insider now owns 55,039 shares of the company’s stock, valued at $880,624. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Tom Sharma sold 4,157 shares of Integral Ad Science stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $16.00, for a total transaction of $66,512.00. Following the sale, the insider now owns 55,039 shares of the company’s stock, valued at approximately $880,624. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Vep Group, Llc sold 5,220,000 shares of the business’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $18.13, for a total transaction of $94,638,600.00. Following the sale, the insider now directly owns 77,660,001 shares in the company, valued at approximately $1,407,975,818.13. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,761,758 shares of company stock valued at $267,858,510. Corporate insiders own 2.00% of the company’s stock.
Institutional Trading of Integral Ad Science
Hedge funds have recently modified their holdings of the company. Wellington Management Group LLP increased its position in Integral Ad Science by 15,557.5% during the first quarter. Wellington Management Group LLP now owns 3,152,174 shares of the company’s stock valued at $43,500,000 after acquiring an additional 3,132,042 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Integral Ad Science by 77.2% during the third quarter. Vanguard Group Inc. now owns 4,752,765 shares of the company’s stock valued at $34,409,000 after buying an additional 2,070,907 shares during the period. Engle Capital Management L.P. bought a new position in shares of Integral Ad Science during the fourth quarter valued at approximately $8,790,000. BlackRock Inc. lifted its stake in shares of Integral Ad Science by 47.1% during the 1st quarter. BlackRock Inc. now owns 1,603,564 shares of the company’s stock worth $22,129,000 after acquiring an additional 513,654 shares during the last quarter. Finally, Citadel Advisors LLC boosted its holdings in Integral Ad Science by 109.8% during the 3rd quarter. Citadel Advisors LLC now owns 977,467 shares of the company’s stock valued at $7,077,000 after acquiring an additional 511,667 shares during the period. 96.39% of the stock is owned by hedge funds and other institutional investors.
About Integral Ad Science
(Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Germany, Italy, Singapore, Australia, France, Japan, and India. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integral Ad Science, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Integral Ad Science wasn’t on the list.
While Integral Ad Science currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report